Stockscreener 앱 받기
32.29
2.00%
-0.66
시간 외 거래:
32.29
전일 마감가:
$32.95
열려 있는:
$33.1
하루 거래량:
1.12M
Relative Volume:
0.96
시가총액:
$1.96B
수익:
$277.49M
순이익/손실:
$-192.14M
주가수익비율:
-9.6101
EPS:
-3.36
순현금흐름:
$-95.52M
1주 성능:
-1.40%
1개월 성능:
-16.89%
6개월 성능:
-24.01%
1년 성능:
-31.92%
1일 변동 폭
$31.74
$33.52
1주일 범위
$30.72
$33.68
52주 변동 폭
$30.72
$60.90
트위스트 바이오사이언스 Stock (TWST) Company Profile
명칭
Twist Bioscience Corp
전화
800-719-0671
주소
681 GATEWAY BLVD., SOUTH SAN FRANCISCO, CA
TWST을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TWST
Twist Bioscience Corp
|
32.29 | 1.96B | 277.49M | -192.14M | -95.52M | -3.36 |
|
TMO
Thermo Fisher Scientific Inc
|
428.95 | 153.65B | 42.90B | 6.52B | 6.72B | 17.05 |
|
DHR
Danaher Corp
|
196.61 | 136.01B | 23.82B | 3.77B | 4.90B | 5.15 |
|
IDXX
Idexx Laboratories Inc
|
509.13 | 38.10B | 3.93B | 894.97M | 837.70M | 10.82 |
|
A
Agilent Technologies Inc
|
115.42 | 30.00B | 6.53B | 1.26B | 1.31B | 4.35 |
|
IQV
Iqvia Holdings Inc
|
150.68 | 25.29B | 15.50B | 1.33B | 2.16B | 7.34 |
트위스트 바이오사이언스 Stock (TWST) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-12-13 | 개시 | Wolfe Research | Outperform |
| 2024-06-04 | 개시 | Guggenheim | Buy |
| 2024-01-17 | 업그레이드 | Goldman | Neutral → Buy |
| 2023-09-27 | 개시 | Berenberg | Buy |
| 2023-01-05 | 개시 | Scotiabank | Sector Outperform |
| 2023-01-03 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2022-03-02 | 재개 | Cowen | Outperform |
| 2021-10-15 | 재개 | Cowen | Outperform |
| 2021-06-29 | 개시 | William Blair | Outperform |
| 2021-06-04 | 개시 | Goldman | Neutral |
| 2021-04-12 | 개시 | Piper Sandler | Overweight |
| 2021-02-05 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2021-01-04 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2020-10-20 | 개시 | SVB Leerink | Mkt Perform |
| 2019-05-31 | 개시 | Evercore ISI | Outperform |
| 2018-11-26 | 개시 | JP Morgan | Neutral |
모두보기
트위스트 바이오사이언스 주식(TWST)의 최신 뉴스
Cathie Wood’s ARK adjusts positions, selling Archer Aviation, buying Twist Bioscience - Investing.com India
Twist Bioscience Corporation Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - Business Wire
Billionaire Nicholas J. Pritzker’s 8 Stocks with Huge Upside Potential - Insider Monkey
Twist Bioscience Corporation (TWST): Among Nicholas J. Pritzker’s Stock Picks with Huge Upside Potential - Yahoo Finance
Twist Bioscience and Ginkgo Bioworks update DNA supply deal - Investing.com
Twist Bioscience and Ginkgo Bioworks Revise Collaboration - Business Wire
Twist Bioscience Executives Sell Shares to Cover Tax Obligations - TradingView
Twist Bioscience: Expansion Efforts Continue To Face Challenges (NASDAQ:TWST) - Seeking Alpha
Goldman Sachs Adjusts Price Target for Twist Bioscience (TWST) | - GuruFocus
Where Twist Bioscience Stands With Analysts - Benzinga
Goldman Sachs Adjusts Price Target for Twist Bioscience (TWST) | TWST Stock News - GuruFocus
Guggenheim Reiterates Buy Rating on Twist Bioscience (TWST) with $50 Price Target | TWST Stock News - GuruFocus
Twist Bioscience (TWST) Price Target Lowered by Baird | TWST Sto - GuruFocus
Twist Bioscience (TWST) Price Target Lowered by Baird | TWST Stock News - GuruFocus
JP Morgan Adjusts Price Target for Twist Bioscience (TWST) | TWS - GuruFocus
JP Morgan Adjusts Price Target for Twist Bioscience (TWST) | TWST Stock News - GuruFocus
Twist Bioscience Corporation (NASDAQ:TWST) Q2 2025 Earnings Call Transcript - Insider Monkey
Twist Bioscience (TWST) Price Target Adjusted by Analyst | TWST Stock News - GuruFocus
JPMorgan Adjusts Price Target for Twist Bioscience (TWST) | TWST Stock News - GuruFocus
Twist Bioscience Corp (TWST) Q2 2025 Earnings Call Highlights: R - GuruFocus
Twist Bioscience Corp (TWST) Q2 2025 Earnings Call Highlights: Record Revenue and Strategic ... - Yahoo Finance
Twist Bioscience stock holds $58 target, safe from headwinds By Investing.com - Investing.com Canada
Twist Bioscience: Fiscal Q2 Earnings Snapshot - MySA
Twist Bioscience (TWST) Reports Q2 Revenue and New Business Laun - GuruFocus
Twist Bioscience stock holds $58 target, safe from headwinds - Investing.com Australia
Leerink maintains $40 target on Twist Bioscience stock - Investing.com
Twist Bioscience (TWST) Unveils DNA Storage Spin-Off and Reports Strong Q2 Growth - GuruFocus
Barclays maintains $45 target on Twist Bioscience stock - Investing.com
Twist Bioscience earnings missed by $0.05, revenue topped estimates - Investing.com Canada
Twist Bioscience (TWST) Q2 Earnings: Revenue Surges but EPS Falls Short - GuruFocus
Twist Bioscience Corp Q2 FY25 Earnings: Revenue Surpasses Estima - GuruFocus
Twist Bioscience (TWST) Spins Off Atlas Data Storage - GuruFocus
Earnings call transcript: Twist Bioscience Q2 2025 revenue rises, stock reacts positively - Investing.com Nigeria
TWIST BIOSCIENCE Earnings Results: $TWST Reports Quarterly Earnings - Nasdaq
Twist Bioscience (TWST) reports Q2 loss, tops revenue estimates - FXStreet
Twist Bioscience Corp reports results for the quarter ended March 31Earnings Summary - TradingView
Twist Bioscience Q2 2025 slides: revenue grows 23%, margins approach 50% target - Investing.com
Twist Bioscience (TWST) Reports Q2 Loss, Tops Revenue Estimates - Yahoo Finance
Twist Bioscience Announces Fiscal 2025 Second Quarter Financial Results - marketscreener.com
Twist Bioscience Spins Out DNA Data Storage As Independent Company - marketscreener.com
Twist Bioscience Corp Q2 FY25 Earnings: Revenue Surpasses Estimates at $92.8M, EPS Misses at -$0.58 - GuruFocus
Twist Bioscience Launches Atlas Data Storage as Independent Company With $155M Backing - marketscreener.com
Twist Bioscience (TWST) Reports Q2 Revenue and New Business Launch | TWST Stock News - GuruFocus
Twist Bioscience (TWST) Spins Off DNA Storage Unit as Atlas Data Storage | TWST Stock News - GuruFocus
Twist Bioscience Fiscal Q2 Loss Narrows, Revenue Rises; 2025 Sales Outlook Maintained - marketscreener.com
Twist Bioscience Spins Out DNA Data Storage as Independent Company - Business Wire
Twist Bioscience (TWST) Projected to Post Earnings on Monday - Defense World
What's Next: Twist Bioscience's Earnings Preview - Nasdaq
What To Expect From Twist Bioscience Corp (TWST) Q2 2025 Earnings - GuruFocus
Deeper Dive: Understanding Twist Bioscience Corp (TWST) Through its Various Ratios - DWinneX
Twist Bioscience: Experiencing Solid Growth But Significantly Overvalued (NASDAQ:TWST) - Seeking Alpha
트위스트 바이오사이언스 (TWST) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.80%
0.21%
자본화:
|
볼륨(24시간):